Home LiteratureArticle Details
PMID: 7739538 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Ligand-independent activation of the platelet-derived growth factor beta receptor: requirements for bovine papillomavirus E5-induced mitogenic signaling.

Molecular and cellular biology ·Vol. 15 ·No. 5 ·1995-00-00 ·Pages 2570-81

Drummond-Barbosa D, Vaillancourt RR, Kazlauskas A, DiMaio D

Abstract

The E5 protein of bovine papillomavirus type 1 binds to and activates the endogenous platelet-derived growth factor (PDGF) beta receptor in fibroblasts, resulting in cell transformation. We have developed a functional assay to test the ability of PDGF beta receptor mutants to mediate a mitogenic signal initiated by the E5 protein. Lymphoid Ba/F3 cells are strictly dependent on interleukin-3 for growth, but coexpression of the wild-type PDGF beta receptor and the E5 or v-sis-encoded protein generated a mitogenic signal which allowed Ba/F3-derived cells to proliferate in the absence of interleukin-3. In these cells, the E5 protein bound to and caused increased tyrosine phosphorylation of both the mature and the precursor forms of the wild-type PDGF beta receptor. The tyrosine kinase activity of the receptor was necessary for E5-induced receptor tyrosine phosphorylation and mitogenic activity but not for complex formation with the E5 protein. In contrast, the PDGF-binding domain of the receptor was not required for complex formation with the E5 protein, E5-induced tyrosine phosphorylation or mitogenic activity, demonstrating that E5-mediated receptor activation is ligand independent. Analysis of receptor mutants lacking various combinations of tyrosine phosphorylation sites revealed that the E5 and v-sis-encoded proteins display similar requirements for signaling and suggested that the wild-type PDGF beta receptor can generate multiple independent mitogenic signals. Importantly, these mutants dissociated two activities of the PDGF beta receptor tyrosine kinase, both of which are required for sustained mitogenic signaling: (i) receptor autophosphorylation and creation of binding sites for SH2 domain-containing proteins and (ii) phosphorylation of substrates other than the receptor itself.

MeSH Terms
Animals Binding Sites Bovine papillomavirus 1/genetics,metabolism Cell Division Cell Line Humans Ligands Mice Mitogens Mutation Oncogene Proteins, Viral/genetics,metabolism Phosphorylation Protein-Tyrosine Kinases/genetics,metabolism Receptors, Platelet-Derived Growth Factor/genetics,metabolism Signal Transduction
Chemicals
Ligands Mitogens Oncogene Proteins, Viral oncogene protein E5, Bovine papillomavirus type 1 Protein-Tyrosine Kinases Receptors, Platelet-Derived Growth Factor
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Drummond-Barbosa D
Department of Genetics, Yale University School of Medicine, New Haven, Connecticut 06510, USA.
Vaillancourt R R
Kazlauskas A
DiMaio D
References (45)
45 references, click to expand
  1. Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus.
    Nature. 1983 Jul 7-13;304(5921):35-9 PMID: 6306471
  2. Activation of the SH2-containing phosphotyrosine phosphatase SH-PTP2 by its binding site, phosphotyrosine 1009, on the human platelet-derived growth factor receptor.
    J Biol Chem. 1993 Oct 15;268(29):21478-81 PMID: 7691811
  3. Il-3-dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo.
    Cell. 1985 Jul;41(3):727-34 PMID: 3924409
  4. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production.
    Mol Cell Biol. 1986 Aug;6(8):2895-902 PMID: 3785217
  5. Demonstration that a chemically synthesized BPV1 oncoprotein and its C-terminal domain function to induce cellular DNA synthesis.
    Cell. 1987 Dec 4;51(5):795-802 PMID: 3677173
  6. Direct interaction between Shc and the platelet-derived growth factor beta-receptor.
    J Biol Chem. 1994 May 27;269(21):15337-43 PMID: 8195171
  7. Cellular transformation by a transmembrane peptide: structural requirements for the bovine papillomavirus E5 oncoprotein.
    Proc Natl Acad Sci U S A. 1994 May 24;91(11):4634-8 PMID: 8197111
  8. The bovine papillomavirus type 1 E5 transforming protein specifically binds and activates the beta-type receptor for the platelet-derived growth factor but not other related tyrosine kinase-containing receptors to induce cellular transformation.
    J Virol. 1994 Jul;68(7):4432-41 PMID: 8207816
  9. Tyr-716 in the platelet-derived growth factor beta-receptor kinase insert is involved in GRB2 binding and Ras activation.
    Mol Cell Biol. 1994 Oct;14(10):6715-26 PMID: 7935391
  10. Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice.
    Genes Dev. 1994 Aug 15;8(16):1888-96 PMID: 7958864
  11. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges.
    Proc Natl Acad Sci U S A. 1988 Sep;85(17):6460-4 PMID: 3413107
  12. 44-amino-acid E5 transforming protein of bovine papillomavirus requires a hydrophobic core and specific carboxyl-terminal amino acids.
    Mol Cell Biol. 1988 Oct;8(10):4071-8 PMID: 2847028
  13. Signal transduction by the platelet-derived growth factor receptor.
    Science. 1989 Mar 24;243(4898):1564-70 PMID: 2538922
  14. Role of tyrosine kinase and membrane-spanning domains in signal transduction by the platelet-derived growth factor receptor.
    Mol Cell Biol. 1988 Dec;8(12):5126-31 PMID: 2854192
  15. The E5 oncoprotein of bovine papillomavirus is oriented asymmetrically in Golgi and plasma membranes.
    Virology. 1989 May;170(1):334-9 PMID: 2541554
  16. Autophosphorylation of the PDGF receptor in the kinase insert region regulates interactions with cell proteins.
    Cell. 1989 Sep 22;58(6):1121-33 PMID: 2550144
  17. The bovine papillomavirus E5 transforming protein can stimulate the transforming activity of EGF and CSF-1 receptors.
    Cell. 1989 Oct 6;59(1):21-32 PMID: 2551505
  18. Mutations of the platelet-derived growth factor receptor that cause a loss of ligand-induced conformational change, subtle changes in kinase activity, and impaired ability to stimulate DNA synthesis.
    Mol Cell Biol. 1989 Oct;9(10):4473-8 PMID: 2479827
  19. Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor.
    Nature. 1990 Feb 22;343(6260):762-4 PMID: 2154701
  20. Friend spleen focus-forming virus glycoprotein gp55 interacts with the erythropoietin receptor in the endoplasmic reticulum and affects receptor metabolism.
    Proc Natl Acad Sci U S A. 1990 Jun;87(11):4139-43 PMID: 2161534
  21. Increase of the catalytic activity of phospholipase C-gamma 1 by tyrosine phosphorylation.
    Science. 1990 Nov 30;250(4985):1253-6 PMID: 1700866
  22. Oncogenes and signal transduction.
    Cell. 1991 Jan 25;64(2):281-302 PMID: 1846320
  23. Activation of the platelet-derived growth factor receptor by the bovine papillomavirus E5 transforming protein.
    EMBO J. 1991 Apr;10(4):845-55 PMID: 1849073
  24. Functions of the major tyrosine phosphorylation site of the PDGF receptor beta subunit.
    Cell Regul. 1991 Jun;2(6):413-25 PMID: 1653029
  25. Distinct phosphotyrosines on a growth factor receptor bind to specific molecules that mediate different signaling pathways.
    Cell. 1992 May 1;69(3):413-23 PMID: 1374684
  26. GTPase-activating protein and phosphatidylinositol 3-kinase bind to distinct regions of the platelet-derived growth factor receptor beta subunit.
    Mol Cell Biol. 1992 Jun;12(6):2534-44 PMID: 1375321
  27. Localization of bovine papillomavirus type 1 E5 protein to transformed basal keratinocytes and permissive differentiated cells in fibropapilloma tissue.
    Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5665-9 PMID: 1319069
  28. IL-2 and EGF receptors stimulate the hematopoietic cell cycle via different signaling pathways: demonstration of a novel role for c-myc.
    Cell. 1992 Jul 10;70(1):57-67 PMID: 1535827
  29. Stable association between the bovine papillomavirus E5 transforming protein and activated platelet-derived growth factor receptor in transformed mouse cells.
    Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):6736-40 PMID: 1323117
  30. Identification of two C-terminal autophosphorylation sites in the PDGF beta-receptor: involvement in the interaction with phospholipase C-gamma.
    EMBO J. 1992 Nov;11(11):3911-9 PMID: 1396585
  31. Structural and functional studies on platelet-derived growth factor.
    EMBO J. 1992 Dec;11(12):4251-9 PMID: 1425569
  32. The BPV-1 E5 protein, the 16 kDa membrane pore-forming protein and the PDGF receptor exist in a complex that is dependent on hydrophobic transmembrane interactions.
    EMBO J. 1992 Dec;11(13):4851-9 PMID: 1334459
  33. Tyrosines 1021 and 1009 are phosphorylation sites in the carboxy terminus of the platelet-derived growth factor receptor beta subunit and are required for binding of phospholipase C gamma and a 64-kilodalton protein, respectively.
    Mol Cell Biol. 1993 Jan;13(1):133-43 PMID: 7678051
  34. Specific phosphopeptide binding regulates a conformational change in the PI 3-kinase SH2 domain associated with enzyme activation.
    EMBO J. 1993 Feb;12(2):795-802 PMID: 8382612
  35. Phosphorylation sites at the C-terminus of the platelet-derived growth factor receptor bind phospholipase C gamma 1.
    Mol Biol Cell. 1993 Jan;4(1):49-57 PMID: 8443409
  36. Phospholipase C-gamma 1 and phosphatidylinositol 3 kinase are the downstream mediators of the PDGF receptor's mitogenic signal.
    Cell. 1993 Apr 23;73(2):321-34 PMID: 7682895
  37. Platelet-derived growth factor receptor mediates activation of ras through different signaling pathways in different cell types.
    Mol Cell Biol. 1993 Jun;13(6):3706-13 PMID: 8388543
  38. Identification of two juxtamembrane autophosphorylation sites in the PDGF beta-receptor; involvement in the interaction with Src family tyrosine kinases.
    EMBO J. 1993 Jun;12(6):2257-64 PMID: 7685273
  39. Two signaling molecules share a phosphotyrosine-containing binding site in the platelet-derived growth factor receptor.
    Mol Cell Biol. 1993 Nov;13(11):6889-96 PMID: 7692233
  40. Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation.
    Cell. 1994 Apr 22;77(2):307-16 PMID: 8168137
  41. Specific interaction between the bovine papillomavirus E5 transforming protein and the beta receptor for platelet-derived growth factor in stably transformed and acutely transfected cells.
    J Virol. 1994 Jun;68(6):3582-92 PMID: 8189497
  42. Platelet-derived growth factor receptor can mediate tumorigenic transformation by the bovine papillomavirus E5 protein.
    Mol Cell Biol. 1993 Jul;13(7):4137-45 PMID: 8321218
  43. The 64-kDa protein that associates with the platelet-derived growth factor receptor beta subunit via Tyr-1009 is the SH2-containing phosphotyrosine phosphatase Syp.
    Proc Natl Acad Sci U S A. 1993 Aug 1;90(15):6939-43 PMID: 7688466
  44. Transformation-specific interaction of the bovine papillomavirus E5 oncoprotein with the platelet-derived growth factor receptor transmembrane domain and the epidermal growth factor receptor cytoplasmic domain.
    J Virol. 1993 Sep;67(9):5303-11 PMID: 8394451
  45. Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences.
    Nature. 1984 Feb 9-15;307(5951):521-7 PMID: 6320011
Article Info
Journal
Molecular and cellular biology
Abbr.
Mol Cell Biol
ISSN
0270-7306
Published
1995-00-00
Pages
2570-81
Language
English
Region
United States
NLM ID
8109087
PMCID
PMC230487
Subset
IM
Grants
NCI NIH HHS · CA37157 · United States
NCI NIH HHS · CA55063 · United States
NIGMS NIH HHS · GM48339 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]